Stock OGN ORGANON & CO.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Organon & Co.

Equities

OGN

US68622V1061

Market Closed - Nyse
Other stock markets
 04:00:02 2024-06-07 pm EDT 		5-day change 1st Jan Change
20.75 USD +0.39% Intraday chart for Organon & Co. -2.72% +43.90%
May. 24 Organon, Henlius' Denosumab Biosimilar HLX14 Gets European Validation MT
May. 24 Shanghai Henlius Biotech, Inc. and Organon Announces That the European Medicines Agency Has Validated the Marketing Authorization Applications for Hlx14 CI
fa0722abe8d5.K3QNLI1sv19C2dLF9oD4sWF28O9tbB73Fy-vUHmZ5_Q.XUdFbcpUyTdx4Z-mvbWn01gQx9w6FCqfb2H5IjXeiqBtEGxF6QvlLyiV5g~e0650ef66a98cd776f390cc31bef0445
  1. Stock Market
  2. Equities
  3. OGN Stock
  4. Charts Organon & Co.
  5. News Chart